M&As this week: Aoxin Q&M Dental Group, Zevacor Pharma, Amsino Medical Group

18 May 2017 (Last Updated November 22nd, 2018 11:23)

Dental equipment developer Aoxin Q&M Dental Group has agreed to acquire 100% of the issued and paid-up share capital of Shenyang Qingaomei Oral Restorative Technology (SYQM) for a purchase consideration of $2.45m.

Dental equipment developer Aoxin Q&M Dental Group has agreed to acquire 100% of the issued and paid-up share capital of Shenyang Qingaomei Oral Restorative Technology (SYQM) for a purchase consideration of $2.45m.

Aoxin has concurrently signed a memorandum of understanding (MoU) to acquire Zhuanghe City Chengguan Street Jiadawei Dental Clinic (ZHJDW) for $1.22m.

The acquisitions will enable Aoxin to expand into dental-related industries in Northern China.

"The acquisitions will enable Aoxin to expand into dental-related industries in Northern China."

Illinois Health and Science (IHS) has signed a definitive agreement to sell Zevacor Pharma, a developer of PET radiopharmaceutical products, to molecular imaging company, Sofie Biosciences.

The acquirer will take over Zevacor Pharma’s manufacturing and distribution network.

In a $13.3m deal, Jiangsu Yuyue Medical Equipment and Supply Company intends to acquire 19.33% stake in Amsino Medical Group Company.